Regulatory and government disclosure obligations increasingly require companies to submit highly sensitive technical and commercial information that would otherwise qualify as trade secrets. Join this session to find out how in-house teams manage regulatory compliance without undermining future trade secret protection or litigation position.
- Understand where US regulatory disclosures most commonly weaken trade secret claims, including FDA filings, cybersecurity reporting, and other mandatory submissions.
- Learn how FOIA and government access risks are assessed in practice, and what courts look for when companies argue information remained confidential after disclosure.
- Identify procurement and government contracting disclosures that can compromise trade secret protection, and how to mitigate those risks upfront.
- Take away practical strategies for structuring regulatory submissions to preserve trade secret status and support reasonable-measures arguments in future disputes.
Speaker(s):

Kim Jessum
Chief IP Counsel
Heraeus

Matt Murphy
Partner
Axinn Veltrop & Harkrider LLP
Time:
9:30am - 10:15am
Agenda Track No.:
Track 1
Session Type:
General Session (Presentation)
Force Inline Description:
0